Skip to main content
Caplight Logo









Spimed-AI

Spimed-AI

Private
ParisHealthcare & Life Scienceshttps://www.spimed-ai.com/

Last Round

Grant

Jul 7, 2022

Total Funding Raised

$566,000

Company Overview

Spimed-AI is a medical diagnostics company that develops artificial intelligence-powered software for the automated detection and classification of coronary lesions from coronary CT angiography (CCTA) scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

coronary computed tomography angiographyCCTAfractional flow reserveFFRmedical imaging AIcardiac imagingdiagnostic softwarecoronary artery diseaseCAD-RADSradiology AIclinical decision supportmedical SaaSAI radiologycardiology softwareautomated lesion detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spimed-AI Comparables

Compare Spimed-AI with similar companies based on industry and business-model similarity.

Spimed-AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caristo Diagnostics
81%
Artrya Ltd
80%
Cleerly
78%

Spimed-AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 7, 2022
AcceleratorJan 1, 2021

Key People

Founding team and executive leadership

JEAN-FRANCOIS PAUL

CEO and FOUNDER

Founding Team

Henri Giroussens

Chief Technology Officer, Data Scientist

Executive Team

Loïc Paul Venturine

COO, Directeur juridique

Executive Team

Spimed-AI Investors

Notable investors and investment history

Spimed-AI investors
InvestorRounds
Paris Biotech SantéAccelerator
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 90% MoM.

  • Feb 2, 2026

    Grew 35% QoQ, from 17 to 23 employees.

Spimed-AI Filings

Explore SEC and related filing metadata, where available.

Spimed-AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spimed-AI's valuation, stock price, and market status.

Is Spimed-AI a public or private company?

Spimed-AI is a private company.

What is the current stock price of Spimed-AI?

Spimed-AI is a private company with no public stock price. No recent secondary market data is available.

How much is Spimed-AI worth (valuation)?

Valuation information for Spimed-AI is not publicly available.

Can I buy Spimed-AI stock?

Spimed-AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spimed-AI's last funding round?

Spimed-AI's most recent funding round was Grant on July 7, 2022.

Who are the main investors in Spimed-AI?

Key investors in Spimed-AI include Paris Biotech Santé, Bpifrance.

Will Spimed-AI IPO soon?

No public IPO plans have been announced for Spimed-AI.

How can I track Spimed-AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spimed-AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range20
Year Founded2019
Last FundingJul 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?